Garlic Supplement Dissolution Standards Clinical Trial Use Suggested
This article was originally published in The Tan Sheet
Executive Summary
Future clinical trials on garlic and cardiovascular disease should use supplements that pass U.S. Pharmacopeia dissolution standards for high allicin release, a researcher suggested at a National Institutes of Health conference June 12 in Bethesda, Md.
You may also be interested in...
Lichtwer Kwai Garlic Effects On Cholesterol "Debatable" - Meta-Analysis
Clinical studies examining the efficacy of different garlic formulations at comparable doses "would help determine whether garlic has a specific effect on cholesterol levels," researchers conclude in a meta-analysis appearing in the Sept. 19 Annals of Internal Medicine.
Lichtwer Kwai Garlic Effects On Cholesterol "Debatable" - Meta-Analysis
Clinical studies examining the efficacy of different garlic formulations at comparable doses "would help determine whether garlic has a specific effect on cholesterol levels," researchers conclude in a meta-analysis appearing in the Sept. 19 Annals of Internal Medicine.
Lichtwer Kwai Garlic Effects On Cholesterol "Debatable" - Meta-Analysis
Clinical studies examining the efficacy of different garlic formulations at comparable doses "would help determine whether garlic has a specific effect on cholesterol levels," researchers conclude in a meta-analysis appearing in the Sept. 19 Annals of Internal Medicine.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: